Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-08-15), Zydus Wellness's 9-Day RSI is 33.60.
The industry rank for Zydus Wellness's 9-Day RSI or its related term are showing as below:
BOM:531335's 9-Day RSI is ranked better than 91.03% of 2107
companies
in the Consumer Packaged Goods industry
Industry Median: 51.3
vs BOM:531335: 33.60
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Zydus Wellness 9-Day RSI Related Terms
BOM:531335 vs KHC, GIS: 9-Day RSI Comparison
For the Packaged Foods subindustry, Zydus Wellness's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zydus Wellness 9-Day RSI vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Zydus Wellness's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Zydus Wellness's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zydus Wellness (BOM:531335) has a 9-Day RSI of 33.60 as of Aug. 15, 2026. According to the industry distribution chart, Zydus Wellness ranks #189 out of 2107 companies in the Consumer Packaged Goods industry, placing it in the top 9%.
Is Zydus Wellness' 9-Day RSI too high?
Zydus Wellness' current 9-Day RSI is 33.60. The Consumer Packaged Goods industry median 9-Day RSI is 51.30. Zydus Wellness' value of 33.60 is 34.5% below this industry median. Based on the distribution chart, Zydus Wellness ranks #189 out of 2107 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Zydus Wellness has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zydus Wellness' 9-Day RSI compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Zydus Wellness ranks #189 out of 2107 companies for 9-Day RSI. This places Zydus Wellness in the top 9% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 51.30. Zydus Wellness' value of 33.60 is 34.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Consumer Packaged Goods company?
The median 9-Day RSI among Consumer Packaged Goods companies is 51.30, based on 2,107 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zydus Wellness's current 9-Day RSI of 33.60 is 34.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median 9-Day RSI is 51.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zydus Wellness's current 9-Day RSI is 33.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zydus Wellness stock overvalued right now?
Based on GuruFocus' analysis, Zydus Wellness (BOM:531335) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹678.18, compared to a current price of ₹510.30 — trading 24.8% below its estimated fair value. The current 9-Day RSI is 33.60 and 34.5% below the Consumer Packaged Goods industry median of 51.30. Zydus Wellness' overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Zydus Wellness (BOM:531335), the current 9-Day RSI is 33.60 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zydus Wellness (BOM:531335) Overvalued in 2026?
Based on GuruFocus' analysis, Zydus Wellness stock appears to be undervalued.
The current stock price of ₹510.30 is trading 24.8% below its estimated GF Value™ of ₹678.18.
GuruFocus considers Zydus Wellness to be Modestly Undervalued.
Key valuation signals for BOM:531335:
9-Day RSI: 33.60
GF Value™: ₹678.18 vs. price of ₹510.30 (24.8% below fair value)
Industry Position: 34.5% below the Consumer Packaged Goods median (#189 of 2107)
No single metric tells the full story. See the BOM:531335 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zydus Wellness Ltd is engaged in the production and distribution of health and wellness products. It has several brands, including Everyuth, Sugar-Free, and Nutralite. The company offers specialty skincare products under the brand Everyuth Naturals. Zydus's sugar-free product portfolio, a sugar substitute category, consists of Sugar-Free gold for tabletop usage and Sugar-Free Natura for culinary usage. The firm also offers healthy foods, including Nutralite, a healthy butter substitute. Company brands includes: Complan, Sugar Free, Glucon-D, Everyuth, Nycil, Nutralite, and Others.
87GF Score
Get the complete analysis for BOM:531335
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531335 has been successfully added to your 
